Literature DB >> 22112547

AβPP accumulation and/or intraneuronal amyloid-β accumulation? The 3xTg-AD mouse model revisited.

Oliver Wirths1, Annika Dins, Thomas A Bayer.   

Abstract

The triple-transgenic Alzheimer's disease (AD) mouse model, 3xTg-AD, played an important role in supporting the intraneuronal amyloid-β (Aβ) hypothesis in AD. However, recent evidence claims that the 3xTg-AD mice accumulate amyloid-β protein precursor (AβPP) instead of Aβ within neurons. In the present report, we re-investigated the 3xTg-AD mouse model and confirmed recent findings of age-dependent AβPP accumulations. In addition, intraneuronal Aβ was detected mainly in the neocortex using conformation-specific as well as antibodies directed against Aβ neo-epitopes. In contrast to previous work, however, only minor levels of intraneuronal Aβ were detected in the CA1 region of the hippocampus in aged 3xTg-AD mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22112547     DOI: 10.3233/JAD-2011-111529

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  15 in total

Review 1.  The keystone of Alzheimer pathogenesis might be sought in Aβ physiology.

Authors:  D Puzzo; W Gulisano; O Arancio; A Palmeri
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

2.  Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease.

Authors:  Sonia George; Géraldine H Petit; Gunnar K Gouras; Patrik Brundin; Roger Olsson
Journal:  ACS Chem Neurosci       Date:  2013-09-25       Impact factor: 4.418

3.  Age-associated evolution of plasmatic amyloid in mouse lemur primates: relationship with intracellular amyloid deposition.

Authors:  Maggie Roy; Cécile Cardoso; Olène Dorieux; Carole Malgorn; Stéphane Epelbaum; Fanny Petit; Audrey Kraska; Emmanuel Brouillet; Benoît Delatour; Martine Perret; Fabienne Aujard; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2014-07-18       Impact factor: 4.673

4.  Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease.

Authors:  Michael W Marlatt; Michelle C Potter; Thomas A Bayer; Henriette van Praag; Paul J Lucassen
Journal:  Curr Top Behav Neurosci       Date:  2013

Review 5.  Amyloid precursor protein processing and bioenergetics.

Authors:  Heather M Wilkins; Russell H Swerdlow
Journal:  Brain Res Bull       Date:  2016-08-18       Impact factor: 4.077

6.  TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.

Authors:  Youngdae Gwon; Tae-In Kam; Seo-Hyun Kim; Sungmin Song; Hyejin Park; Bitna Lim; Haneul Lee; Weontae Lee; Dong-Gyu Jo; Yong-Keun Jung
Journal:  J Neurosci       Date:  2018-09-05       Impact factor: 6.167

Review 7.  Interaction between α-synuclein and other proteins in neurodegenerative disorders.

Authors:  Kurt A Jellinger
Journal:  ScientificWorldJournal       Date:  2011-10-24

8.  The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus.

Authors:  Inger Lauritzen; Raphaëlle Pardossi-Piquard; Charlotte Bauer; Elizabeth Brigham; Jean-Daniel Abraham; Sébastien Ranaldi; Paul Fraser; Peter St-George-Hyslop; Ophelia Le Thuc; Vanessa Espin; Linda Chami; Julie Dunys; Frédéric Checler
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

9.  Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.

Authors:  Erika Avendaño Guzmán; Yvonne Bouter; Bernhard C Richard; Lars Lannfelt; Martin Ingelsson; Anders Paetau; Auli Verkkoniemi-Ahola; Oliver Wirths; Thomas A Bayer
Journal:  Mol Neurodegener       Date:  2014-04-02       Impact factor: 14.195

10.  Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer's disease.

Authors:  Sonia George; Annica Rönnbäck; Gunnar K Gouras; Géraldine H Petit; Fiona Grueninger; Bengt Winblad; Caroline Graff; Patrik Brundin
Journal:  Acta Neuropathol Commun       Date:  2014-02-11       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.